These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14395815)

  • 1. [Renal elimination of sodium in alcoholic liver cirrhosis with ascites].
    CACHERA R; DARNIS F; LUBETZKY J
    Rev Invest Clin; 1955; 7(1):9-28. PubMed ID: 14395815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of renal sodium elimination in alcoholic cirrhosis with ascites].
    CACHERA R
    Brux Med; 1954 Nov; 34(45):2203-17. PubMed ID: 13209210
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of renal elimination of sodium in alcoholic cirrhosis with ascites].
    CACHERA R; DARNIS F; LUBETZKI J
    Sem Hop; 1953 Nov; 29(70):3613-23. PubMed ID: 13122079
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of disorders of renal elimination of sodium in alcoholic cirrhosis with ascites.
    CACHERA R
    Union Med Can; 1955 Jan; 84(1):8-24. PubMed ID: 14359545
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of renal elimination of water in alcoholic cirrhosis with ascites].
    CACHERA R; DARNIS F; LUBETZKI J
    Sem Hop; 1953 Nov; 29(70):3606-13. PubMed ID: 13122078
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study.
    Linderoth G; Jepsen P; Schønheyder HC; Johnsen SP; Sørensen HT
    Alcohol Clin Exp Res; 2006 Apr; 30(4):636-41. PubMed ID: 16573581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bitter end of long-term alcoholism. Tension to the end].
    Gesslein M; Vierzigmann T
    MMW Fortschr Med; 2005 Oct; 147(40):61. PubMed ID: 16255522
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of female alcoholic who developed liver cirrhosis with small amounts of alcohol by the common use of contraceptive agent].
    Takamatsu M; Ohata M; Sakamoto K; Searashi Y; Takeda K; Suzuki H; Nakajima H; Yamauchi M; Hokkyo K; Toda G; Shinkai N
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Dec; 38(6):492-7. PubMed ID: 14750359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
    Ahloulay M; Bankir L; Lugnier C; Le Bec A; Poirel O; Moreau R; Lebrec D
    Liver Int; 2005 Apr; 25(2):403-9. PubMed ID: 15780066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium retention in rats with liver cirrhosis is associated with increased renal abundance of NaCl cotransporter (NCC).
    Yu Z; Serra A; Sauter D; Loffing J; Ackermann D; Frey FJ; Frey BM; Vogt B
    Nephrol Dial Transplant; 2005 Sep; 20(9):1833-41. PubMed ID: 15956070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 14. 2nd International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis, 18-19 October 2007, Kobe, Japan. Preface.
    Atomi Y; Arii S
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S1. PubMed ID: 18336650
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat.
    Ghali-Ghoul R; Tahseldar-Roumieh R; Sabra R
    Eur J Pharmacol; 2007 Oct; 572(1):49-56. PubMed ID: 17610866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical basic of alcoholic liver injury].
    Jelski W; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2006 Oct; 21(124):376-80. PubMed ID: 17205782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapy of cirrhotic ascites].
    ABIGNOLI E
    Mars Med; 1951; 88(8):378-84. PubMed ID: 14909670
    [No Abstract]   [Full Text] [Related]  

  • 18. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.